Top Players Operating in Allergic Rhinitis Market like Merck, GSK, Sanofi, Cigna, Himalaya, J&J, Chong Kun Dang Pharmaceutical Corp., Faes, Farma

Industry Report “Global Allergic Rhinitis Market Research Report -Forecast To 2023” Provides detail information about strategies used by top key players in the market. The report also gives a broad study of the different market segments and regions with Size, Share and Forecasts.

Global Allergic Rhinitis Market - Overview

Market Research Future (MRFR) has announced a new release on the global allergic rhinitis market. The report provides a thorough understanding of the global allergic rhinitis market’s movement over the forecast period from 2017 to 2023 on the basis of the market’s movement patterns over the historical study period and a study of the market’s key drivers and restraints.

The leading drivers and restraints affecting the global allergic rhinitis market’s growth are studied in the report in detail. The report projects the Global Allergic Rhinitis Market to rise at a CAGR of 7% over the forecast period, rising to a valuation of USD 15 billion by 2023.

GET PREMIUM SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/1547

Allergic rhinitis, also called hay fever, is caused by an allergic reaction to environmental materials such as dander, animal skin, pollen, and mold. The disease is characterized by an itching sensation along and around the respiratory tract and the skin, in addition to a runny nose, sore throat, and sneezing.

Allergic rhinitis is inherited, and if a mother has the disease the child is more likely to have it, too. The only way to prevent allergic rhinitis is to avoid substances that can cause the allergic reaction. Other than this, washing clothes, bedsheets, and other fabrics regularly is also said to be good for preventing allergic rhinitis.

The growing use of nasal sprays and inhalers is likely to be a major driver for the global allergic rhinitis market over the forecast period. As people are becoming more aware about the dangers of allergic rhinitis, the demand for preventive and curative measures against the same is increasing.

The increasing levels of air pollution are also likely to be a major driver for the allergic rhinitis market over the forecast period, as pollution weakens the respiratory system’s natural protective mechanisms and leaves it prone to attacks from allergens and pathogens.

Competitive Analysis

Leading players in the global allergic rhinitis market include Merck & Co. Inc., Sanofi, Himalaya, Chong Kun Dang Pharmaceutical Group, Glenmark Pharmaceutical, Ampio Pharmaceutical Inc., Olain Farm, Hisamitsu Pharmaceutical Co. Inc., Faes Farma, Johnson & Johnson, Cigna, and GlaxoSmithKline.

Global Allergic Rhinitis Market - Segmentation

The global allergic rhinitis market is segmented on the basis of types, treatment, test, and region.

By type, the allergic rhinitis market covers seasonal, perennial, and non-allergic rhinitis. Non-allergic rhinitis holds a tiny share in the market, which is dominated by seasonal allergic rhinitis. Seasonal allergic rhinitis is likely to remain the leading segment in the global allergic rhinitis market over the forecast period due to the high prevalence of allergens during the allergy season.

On the basis of treatment, the allergic rhinitis market is segmented into antihistamines, decongestants, eye drops, nasal sprays, immunotherapy, sublingual immunotherapy (SLIT), and home remedies. The antihistamine segment is further sub-segmented into drugs like Allegra, Clarinex, Xyzal and Zyrtec. The decongestants segment is sub-segmented into Afrin nasal spray, Sudafed, Sudafed PE, and Zyrtec-D.

On the basis of test, the market is segmented into skin tests, igE RAST test, and complete blood count.

OBTAIN PREMIUM RESEARCH REPORT DETAILS @

https://www.marketresearchfuture.com/reports/allergic-rhinitis-market-1547

Detailed Regional Analysis

The global allergic rhinitis market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa on the basis of region.

North America is likely to be the dominant regional player in the global allergic rhinitis market over the forecast period due to the widespread awareness about allergic rhinitis and the growing prevalence of the disease.

The U.S. has the highest incidence rate of hay fever in the world, ensuring North America’s dominance in the global allergic rhinitis market. Europe is also likely to be a major regional player in the global allergic rhinitis market and is likely to hold on to the second position in the market over the forecast period.

Awareness about hay fever is lacking in underdeveloped regions such as Latin America, Africa, and Asia Pacific. Even in regions where people are aware about the disease, most prefer to cure it by herbal home remedies instead of visiting the physician. This is likely to hold back the allergic rhinitis market in Asia Pacific over the forecast period.

Industry Updates

A study in January 2019 found that 20% of the inhabitants of the Indian city of Indore were suffering from allergic rhinitis. This illustrates the lack of awareness about allergic rhinitis in the Asia Pacific market.

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.